NuvoBio Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

NuvoBio General Information

Description

Developer of a bio-medical technology platform designed to expedite the development of peptide therapeutics. The company's platform designs safer, more effective peptides by computationally evolving sequences for high specificity and minimal off-target effects, enabling pharmaceutical and biotechnological researchers to accelerate drug development and expand access to previously unreachable targets.

Contact Information

Website
www.nuvobio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 234 Perley Court
  • Ottawa, Ontario K1S 1V7
  • Canada
+1 (613)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 234 Perley Court
  • Ottawa, Ontario K1S 1V7
  • Canada
+1 (613)

NuvoBio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NuvoBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 12-Mar-2026 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
4. Seed Round Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
2. Accelerator/Incubator 03-Dec-2024 Completed Generating Revenue
1. Accelerator/Incubator 01-Jun-2024 Completed Generating Revenue
To view NuvoBio’s complete valuation and funding history, request access »

NuvoBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NuvoBio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ontario Genomics Accelerator/Incubator Minority
Merck Digital Sciences Studio Accelerator/Incubator Minority
Ontario Bioscience Innovation Organization Not-For-Profit Venture Capital
Capital BioVentures Accelerator/Incubator
Creative Destruction Lab Accelerator/Incubator
To view NuvoBio’s complete investors history, request access »

Ready to get started?

Request a free trial

NuvoBio FAQs

  • When was NuvoBio founded?

    NuvoBio was founded in 2016.

  • Where is NuvoBio headquartered?

    NuvoBio is headquartered in Ottawa, Canada.

  • What is the size of NuvoBio?

    NuvoBio has 6 total employees.

  • What industry is NuvoBio in?

    NuvoBio’s primary industry is Drug Discovery.

  • Is NuvoBio a private or public company?

    NuvoBio is a Private company.

  • What is NuvoBio’s current revenue?

    The current revenue for NuvoBio is .

  • How much funding has NuvoBio raised over time?

    NuvoBio has raised $1.11M.

  • Who are NuvoBio’s investors?

    Ontario Genomics, Merck Digital Sciences Studio, Ontario Bioscience Innovation Organization, Capital BioVentures, and Creative Destruction Lab have invested in NuvoBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process